Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Neutropenia and CYP2C8[original query] |
---|
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jul 27 (21): 3540-6. Gandara David R, Kawaguchi Tomoya, Crowley John, Moon James, Furuse Kiyoyuki, Kawahara Masaaki, Teramukai Satoshi, Ohe Yuichiro, Kubota Kaoru, Williamson Stephen K, Gautschi Oliver, Lenz Heinz Josef, McLeod Howard L, Lara Primo N, Coltman Charles Arthur, Fukuoka Masahiro, Saijo Nagahiro, Fukushima Masanori, Mack Philip |
Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients. Breast cancer research and treatment 2010 Nov 124 (2): 593-8. Rizzo Roberta, Spaggiari Federica, Indelli Monica, Lelli Giorgio, Baricordi Olavio R, Rimessi Paola, Ferlini Alessand |
Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer. Journal of pharmaceutical sciences 2011 Oct 100 (10): 4205-9. Gréen Henrik, Khan Muhammad Suleman, Jakobsen-Falk Ingrid, Åvall-Lundqvist Elisabeth, Peterson Cu |
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer. European journal of clinical pharmacology 2011 Jul 67 (7): 693-700. Bergmann Troels K, Gréen Henrik, Brasch-Andersen Charlotte, Mirza Mansoor R, Herrstedt Jørn, Hølund Berit, du Bois Andreas, Damkier Per, Vach Werner, Brosen Kim, Peterson Cu |
Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer. Basic & clinical pharmacology & toxicology 2012 Feb 110 (2): 199-204. Bergmann Troels K, Brasch-Andersen Charlotte, Gréen Henrik, Mirza Mansoor R, Skougaard Kristin, Wihl Jessica, Keldsen Nina, Damkier Per, Peterson Curt, Vach Werner, Brøsen K |
Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach. Gene 2014 Jun 543 (1): 69-75. Tulsyan Sonam, Chaturvedi Pankaj, Singh Abhishek Kumar, Agarwal Gaurav, Lal Punita, Agrawal Sushma, Mittal Rama Devi, Mittal Balr |
Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers. Archives of gynecology and obstetrics 2019 May . de Castro Clarissa Lourenço, da Costa Junior Luiz Carlos, Lourenço Letícia Vieira, Seba Karine Souza, da Silva Taiana Sousa Lopes, Vianna-Jorge Rosa |
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC). ESMO open 2020 Dec 6 (1): 100019. Pellegrino B, Cavanna L, Boggiani D, Zamagni C, Frassoldati A, Schirone A, Caldara A, Rocca A, Gori S, Piacentini F, Berardi R, Brandes A A, Foglietta J, Villa F, Todeschini R, Tognetto M, Naldi N, Bortesi B, Montemurro F, Ardizzoni A, Boni L, Musolino |
- Page last reviewed:Feb 1, 2024
- Content source: